Premium
Histological and immunological characteristics of, and the effect of immunosuppressive treatment on, xenograft vasculopathy
Author(s) -
Briffa Norman P.,
Shorthouse Randi,
Chan Jason,
Silva Helio,
Billingham Margaret,
Brazelton Timothy,
Morris Randall E.
Publication year - 2004
Publication title -
xenotransplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.052
H-Index - 61
eISSN - 1399-3089
pISSN - 0908-665X
DOI - 10.1046/j.1399-3089.2003.00099.x
Subject(s) - neointima , leflunomide , antibody , hamster , immunosuppression , transplantation , medicine , immunofluorescence , immune system , antigen , pathology , immunology , restenosis , stent , methotrexate
Like allografts, vascularized xenografts are susceptible to a process of chronic rejection. We have used the hamster‐to‐rat aortic transplant model to study characteristics of this phenomenon and to determine whether it could be controlled or prevented by immunosuppressive therapy. Golden Syrian hamster aortas were transplanted into untreated Lewis rats, athymic rats, and Lewis rats receiving cyclosporin (10 mg/kg), leflunomide (5, 10 or 15 mg/kg), or 10 mg/kg of both drugs. Grafts were harvested on days 2, 7, 14, 28 and 56. Grafts and recipient spleens were analysed using computerized morphometry, immunohistochemistry and immunofluorescence. Blood was taken on various days for the measurement of anti‐hamster antibodies (flow cytometry) and of the leflunomide metabolite A77 127. In untreated rats, by day 56, transplanted aortas developed a cell‐free media with a mature neointimal lesion consisting of actin‐positive cells, CD4 T cells, and macrophages. There were large increases in anti‐hamster immunoglobulin M (IgM) and IgG, collections of proliferating cell nuclear antigen (PCNA)‐positive cells in splenic germinal centres, and IgM, C3 and C5a deposition in aortas. In athymic recipients, the media architecture was preserved, and the changes in the neointima and in anti‐hamster IgM and IgG were markedly abrogated, but not prevented. In Lewis rats receiving leflunomide, absence of circulating or deposited IgM did not prevent neointimal formation by day 14. Combination treatment was the most effective at preventing neointimal formation and humoral changes. Leflunomide monotherapy was the least effective. There were no changes in peak concentrations of the main metabolite of leflunomide over 8 weeks. The hamster‐to‐rat aortic transplant model is suitable for the study of xenograft vasculopathy, the histological and serological changes of which are predominantly T‐cell dependant. Combination treatment with 10 mg/kg of cyclosporin and 10 mg/kg of leflunomide was most effective in preventing xenograft vasculopathy.